神经胶质瘤缓激肽B2受体和nNOS表达水平与胶质瘤病理级别相关关系的研究

被引：4

作者：

薛一雪

刘丽波

刘新

机构：

[1] 中国医科大学基础医学院神经生物学教研室

来源：

解剖科学进展 | 2005年 / 04期

关键词：

缓激肽; B2受体; nNOS; 神经胶质瘤; 病理级别;

D O I：

10.16695/j.cnki.1006-2947.2005.04.009

中图分类号：

R739.4 [神经系肿瘤];

学科分类号：

100214 ;

摘要：

目的分析神经胶质瘤缓激肽B2受体和神经元型一氧化氮合酶(nNOS)表达水平与胶质瘤病理级别的相关关系。方法HE染色进行脑肿瘤的病理诊断及分级,免疫组化法测定不同病理级别神经胶质瘤缓激肽B2受体和nNOS的表达水平。结果神经胶质瘤B2受体和nNOS表达水平均与胶质瘤病理级别呈显著正相关,各病理级别神经胶质瘤B2受体和nNOS的表达水平均为:Ⅰ级(Ⅱ级(Ⅲ级。结论神经胶质瘤B2受体和nNOS表达水平均随着其病理级别的增加而升高,提示二者可作胶质瘤病理分级的标示物。

引用

页码：315 / 317

页数：3

共 8 条

[1]

Increased brain tumor m i-crovessel perm eab ility after intracarotid bradyk in in infusion ism ed i-ated by n itric oxide. Nakano S,Matsukado K and B lack KL. Cancer Research . 1996

[2]

M echan ism of n itric oxide re-lease from the vascu lar endothelial. Busse R,Mu lsh A,Flem ing L,et al. C ircu lation . 1993

[3]

Correlation between brady-k in in-induced b lood-tumor barrier perm eab ility and B2 receptor ex-pression in experim ental brain tumors. L iu YH,Hash izum e K,Chen ZT,et al. Neurological Research . 2001

[4]

N itric oxide and cyclic GMP at-tenuate sensitivity of the b lood-tumor barrier perm eab ility to brady-k in in. Masao S,Gabroe H,L iu Y,et al. Neurological Research . 1998

[5]

D elivery of therapeutic agents to the central nervoussystem:the prob lem s and the possib ilities. Begeley D J. Pharmacology and Therapeutics . 2004

[6]

Pathway across b lood-brain barrier opened by the bradyk in in agon ist,RMP-7. Sanovich E,Bartus RT,Friden PM,et al. B rainRes . 1995

[7]

A Phase I study of concur-rent RMP-7 and carboplatin w ith rad iation therapy for ch ildren w ithnew ly d iagnosed brainstem gliomas. Packer R J,KrailoM,M ehta M,et al. Cancer . 2005

[8]

N itric oxide pro-tects b lood-brain barrier in vitro from hypoxia/reoxygenation-m ed ia-ted in jury. Utepbergenov D I,M ertsch K,Sporbert A,et al. FEBS Letters . 1998

← 1 →